mRNA transcription linked to the morphological and plasma membrane changes induced by cyclic AMP in tumour cells.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects*; D002843:Chromatin / Q000096:biosynthesis; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D006657:Histones / Q000096:biosynthesis; D009363:Neoplasm Proteins / Q000032:analysis / Q000096:biosynthesis; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D012333:RNA, Messenger / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D051381:Rats; D012513:Sarcoma, Experimental; D013806:Theophylline / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*
D000227:Adenine Nucleotides; D002843:Chromatin; D006657:Histones; D009363:Neoplasm Proteins; D009712:Nucleotides, Cyclic; D010726:Phosphodiesterase Inhibitors; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D003994:Bucladesine; D013806:Theophylline; D000242:Cyclic AMP; D012321:DNA-Directed RNA Polymerases; D006152:Cyclic GMP